Fraunhofer Institute for Toxicology and Experimental MedicineThe boards of trustees of the individual Fraunhofer Institutes act as purely advisory bodies to their institute’s management. The members come from academia, industry, and government agencies.
Board of trustees
Members of the board of trustees of Fraunhofer ITEM
As at October 2024
Chairman of the board of trustees
Prof. Clive Page, OBE, Ph.D.School of Cancer and Pharmaceutical Science, King’s College London (UK) |
Members
Dr. Karin Conde-KnapeCorporate Vice President Diabetes, Cardio-Renal and Translational Research, Novo Nordisk A/S (Denmark) |
Prof. Susanne HeroldDirector of the Clinic for Infectiology and Hospital Hygiene, University Hospital Giessen and Marburg |
Prof. Wolfgang HerrFull professor and Head of the Department for Internal Medicine III, University Hospital Regensburg |
Prof. Edith M. HesselChief Scientific Officer, Eligo Bioscience (UK) |
Prof. Ralf HussManaging and Medical Director of BioM BioTech Cluster Development GmbH, Munich |
Prof. Paul-Georg GermannGlobal Head of Chemical and Preclinical Safety (CPS), Biopharma, R&D, Discovery and Development Technologies, Merck Healthcare KGaA |
Prof. Michael P. MannsUniversity Professor, President and Board Member for Research and Education, Hannover Medical School |
Eckhard SchwennerCEO Health-I Business Consulting |
Anna TeschnerHead of the Division of Life Sciences, Humanities, Social Sciences and Academic Libraries, Lower Saxony Ministry of Science and Culture |